Market Closed - Oslo Bors 10:45:00 2024-04-29 am EDT 5-day change 1st Jan Change
180 NOK +2.86% Intraday chart for Medistim ASA +2.27% -15.89%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024
Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 CI
Medistim ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Medistim ASA Proposes Dividend CI
Medistim ASA Announces Board Changes CI
Medistim ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Medistim Asa Proposes Dividend for the Year 2023, Payable on 6 May 2024 CI
Transcript : Medistim ASA, Q4 2023 Earnings Call, Feb 29, 2024
Medistim ASA Opens Direct Sales Office in Sweden CI
Medistim Opens New Sales Office in Sweden MT
Transcript : Medistim ASA, Q3 2023 Earnings Call, Oct 27, 2023
Medistim ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Medistim ASA, H1 2023 Earnings Call, Aug 31, 2023
Medistim ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Medistim Signs Partnership With ROMA-Women Cardiac Surgery Trial MT
Transcript : Medistim ASA, Q1 2023 Earnings Call, Apr 25, 2023
Medistim ASA Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Medistim ASA Approves Dividend for the Financial Year 2022 CI
Medistim ASA Proposes Ordinary Dividend for 2022, Payable on May 05, 2023 CI
Norway's Medistim to Widen Market Coverage in China via New Direct Sales Office MT
Medistim Asa Announces Expanding Market Coverage in China by Establishing A Direct Sales Office CI
Norway's Medistim Expands in Canada MT
Medistim ASA Suggests Dividend CI
Medistim ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Medistim ASA Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chart Medistim ASA
More charts
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
180 NOK
Average target price
190 NOK
Spread / Average Target
+5.56%
Consensus
  1. Stock Market
  2. Equities
  3. MEDI Stock
  4. News Medistim ASA
  5. Medistim Signs Partnership With ROMA-Women Cardiac Surgery Trial